More News of Interest

InVivo Therapeutics Announces Presentation at Combined Canadian Spinal Cord and Ontario Spinal Cord Injury Research Network Meeting

InVivo Therapeutics Holdings Corp. (NVIV) today announced that Kristin Neff, Vice President, Clinical Operations, will present at the Combined Canadian Spinal Cord and Ontario Spinal Cord Injury Research Network Meeting on Saturday, May 13, 2017 at 2:40 PM ET at the Marriott Eaton Center in Toronto, Ontario. Ms. Neff will present an abstract titled “Interim Clinical Results from the Ongoing INSPIRE Pivotal Study to Assess the Safety and Probable Benefit of the Investigational Neuro-Spinal Scaffold for Treatment of Acute Thoracic AIS A Spinal Cord Injury.”

Mark Perrin, Chairman and CEO, said, “The Canadian Spinal Cord and Ontario Spinal Cord Injury Research Network Meeting will be a great opportunity for us to continue to engage with the Canadian spinal cord injury research and care network, and we look forward to providing an update on the INSPIRE clinical results.”

For more information on the INSPIRE study, please visit the company’s ClinicalTrials.gov registration site: http://clinicaltrials.gov/ct2/show/study/NCT02138110.

Latest Posts

Don't Miss